Coya Therapeutics Stock Down 3.79% Since IPO

Benzinga Real-time News · 12/31/2022 05:31

Coya Therapeutics (NASDAQ:COYA) opened up its shares for public trading for the first time since it filed for IPO in November 2022. The company agreed to initially offer 3.05 million shares to the public at $5.00 per share. On its first day of trading, the stock decreased 3.79% from its opening price of $4.75 to its closing price of $4.57.Coya Therapeutics Performance On First Day of TradingAbout Coya Therapeutics and It's IPOCoya Therapeutics, Inc is a clinical-stage biotechnology company developing proprietary treatments focused on the biology and potential therapeutic advantages of regulatory T cells ("Tregs") to target systemic inflammation and neuroinflammation.

View Full Text on the app

Risk disclosure: The above content only represents the opinion of the authors or guests, and does not represent any positions of Futu or constitute any investment advice on the part of Futu. Before making any investment decision, investors should consider the risk factors related to investment products based on their own circumstances and consult professional investment advisers where necessary. Futu makes every effort to verify the authenticity, accuracy, and originality of the above content, but does not make any guarantees or promises.